Follow LF0 researchXLinkedInSubstackFacebookTelegram
tput: No value for $TERM and no -T specified

Research

GeneDx (WGS) Stock Analysis & Research

Latest rating
Sell
Latest report
Aug 9, 2026
Reports
1
Sector
Healthcare

GeneDx Holdings (WGS) develops and sells clinical genetic tests, earning revenue mainly from diagnostic test reports for exome and genome sequencing. It pioneered exome sequencing in 2012 and acquired Fabric Genomics in May 2025 to support international expansion and AI-based interpretation.

Backtesting dashboard with equity curve and drawdown analysis
Quantitative market report dashboard with factor and risk analysis
SEC filing comparison with highlighted document changes